Clincosm LogoSign in Get a demo

primary progressive multiple sclerosis

Showing 26 - 32 of 32
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Mitochondrial Dysfunction and Disease Progression

Completed
  • Clinically Isolated Syndrome
  • +3 more
    • New York, New York
      Icahn School of Medicine
    Feb 19, 2019

    Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial in Baltimore (Rituximab)

    Completed
    • Primary Progressive Multiple Sclerosis
    • Secondary Progressive Multiple Sclerosis
    • Baltimore, Maryland
      The Johns Hopkins Hospital
    Aug 29, 2017

    Primary Progressive Multiple Sclerosis Trial in Worldwide (FTY720, Placebo)

    Terminated
    Has Results
    • Primary Progressive Multiple Sclerosis
    • Newport Beach, California
    • +156 more
    May 9, 2017

    Primary Progressive Multiple Sclerosis Trial in France (tears sampling)

    Completed
    • Primary Progressive Multiple Sclerosis
    • tears sampling
    • Nice, Alpes Maritimes, France
    • +12 more
    Sep 19, 2016

    Primary Progressive Multiple Sclerosis, Multiple Sclerosis, Secondary Progressive Trial in Santiago (Andrographolides, )

    Unknown status
    • Primary Progressive Multiple Sclerosis
    • Multiple Sclerosis, Secondary Progressive
    • Santiago, Metropolitana, Chile
      Multiple Sclerosis Centre, Pontificia Universidad Catolica de Ch
    Oct 24, 2014

    Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis Trial in Christchurch (MIS416)

    Completed
    • Secondary Progressive Multiple Sclerosis
    • Primary Progressive Multiple Sclerosis
    • MIS416
    • Christchurch, Canterbury, New Zealand
      Primorus Clinical Trials, 40 Stewart Street
    Dec 5, 2012

    Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial in Copenhagen (Natalizumab)

    Completed
    • Primary Progressive Multiple Sclerosis
    • Secondary Progressive Multiple Sclerosis
    • Copenhagen, Denmark
      Danish Multiple Sclerosis Center, Section 2082, Rigshospitalet
    Feb 15, 2012